8How to predict prognosis in early rheumatoid arthritis
Section snippets
Why is it important to predict prognosis in early ra?
RA is a very heterogeneous disease, the outcome of which is difficult to predict. Some RA patients (30%) do not develop any erosions, even after considerable disease duration, but the majority of patients do have bone erosions. Radiological damage occurs early in disease; approximately 30% of patients will develop bone erosions within 1 year of disease onset and this percentage increases to 70% by 3 years.4 Radiographic progression in RA can follow a linear or a sigmoid curve, but is more rapid
What are the most reliable markers to predict prognosis in early ra?
Many prognostic factors have been described for RA based on results obtained from several longitudinal studies performed in Europe and North America with different cohorts of early RA patients.20 They include demographic, genetic, clinical, biological and radiological factors, but only a few can really be considered as prognostic markers.
Can we really predict prognosis of early ra?
Prognostic scores have been developed to classify patients according to the severity of joint destruction in low, mild and severe erosive RA. The different predictive scores regroup at least two prognostic factors among the most reliable markers present at baseline or at 1 year. The predictive models are calculated from logistic regression analysis Unfortunately, in most studies, these calculated prognostic scores have not been retested on similar, independent samples to confirm their
Conclusion
In conclusion, stratification of early RA into benign, moderate and severe prognosis is important in order to propose a tailormade therapy. RA prognosis is based on the presence or absence of different prognostic factors that have been identified from longitudinal studies. Some of these factors are interobserver independent, whereas others are subjective and variable. The actual method to assess the prognosis of early RA is not very profitable because it only predicts the severe outcome for a
Summary
Radiological damage and disability are the two main complications of RA. The most reliable prognostic factors of radiological damage are high ESR or CRP, the presence and titre of RF and anti-CCP at baseline, the HLA-DRB1*04 SE alleles, especially homozygotic and HLA-DRB1*0401 allele subtype, and early erosions or radiological score at disease onset. The HAQ score is the best prognostic marker for disability and work loss. Several predictive models for early RA have been developed but not
References (52)
Articular patterns in the early course of rheumatoid arthritis
Am J Med
(1983)- et al.
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis
Hum Immunol
(1999) Environmental factors and the outcome of rheumatoid arthritis
Best Pract Res Clin Rheumatol
(2003)- et al.
The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association
J Rheumatol
(1998) - et al.
Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention
Clin Exp Rheumatol
(2003) - et al.
Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification)
J Rheumatol
(1995) - et al.
The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis
Arthritis Rheum
(1998) - et al.
Work disability in rheumatoid arthritis 10 years after the diagnosis
J Rheumatol
(1999) - et al.
The development of disability in rheumatoid arthritis
Arthritis Rheum
(1986) - et al.
Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup
Arthritis Rheum
(2002)
Functional impairment and disability in early rheumatoid arthritis-development over 5 years
J Rheumatol
Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis
J Rheumatol
The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis
Arthritis Rheum
Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?
Arthritis Rheum
Treatment of early rheumatoid arthritis with Infliximab plus methotrexate or methotrexate alone preliminary results of the ASPIRE trial
Ann Rheum Dis
COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention
Arthritis Rheum
Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial
Arthritis Rheum
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
N Engl J Med
Etanercept (ENBREL) in early erosive rheumatoid arthritis (ERA): clinical and radiographic data
Arthritis Rheum
Prognostic markers of radiographic progression in early rheumatoid arthritis
Arthritis Rheum
Sustained response in early poor prognosis RA after withdrawal of infliximab therapy
Arthritis Rheum
Databases of patients with early rheumatoid arthritis in the USA
Clin Exp Rheumatol
The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
Ann Intern Med
Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
J Clin Invest
Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients
Arthritis Rheum
HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognosis factors in rheumatoid arthritis
Ann Rheum Dis
Cited by (82)
Analysis of serum rheumatoid factors in patients with rheumatoid arthritis in Han, Tibetan and Hui nationalities in Qinghai
2020, International ImmunopharmacologyCitation Excerpt :Many of the biomarkers currently under investigation include products related to the synthesis and degradation of bone/cartilage, inflammation or autoimmune processes. The high erythrocyte sedimentation rate (ESR) level in the early stage of RA predicts long-term radiographic progression [2,3], and C-reactive protein (CRP) is the most commonly used laboratory indicator for detecting RA activity. ESR indicators can suggest early disease activity [4] and have been included in the assessment system for disease activity observations, but their values are influenced by a variety of factors such as gender, age, fibrinogen levels, rheumatoid factor (RF), hyperglobulinemia and anemia [5].
Biotechnology for biomarkers: Towards prediction, screening, diagnosis, prognosis, and therapy
2018, Omics Technologies and Bio-engineering: Towards Improving Quality of LifeApplying data mining techniques for predicting prognosis in patients with rheumatoid arthritis
2020, Healthcare (Switzerland)